Karyopharm Therapeutics director Mansoor Raza Mirza resigns from board effective Sept 8, 2025

Karyopharm Therapeutics Inc.

Mansoor Raza Mirza, M.D. resigned from the Board of Directors due to competing professional demands.
Resignation effective September 8, 2025; not due to any disagreement with the Company.
Consulting agreement with Mirza Consulting terminated effective September 8, 2025.
Dr. Mirza also resigning as Chief Oncologist at Copenhagen University National Medical Center effective Oct 1, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.